Abstract
Although celiac disease (CD) is unrelated directly to the endocrine system, it still deserves mention owing to its close association with other autoimmune diseases, in particular type 1 diabetes and autoimmune thyroid disease. CD is an immune-mediated disease primarily of the small intestine but with a wide spectrum of clinical symptoms that is no longer isolated to the gastrointestinal tract. The classic presentation of CD occurs in a young child with growth failure, diarrhea, abdominal distension, and irritability shortly following the introduction of gluten in the diet. However, the clinical presentation of this disease has changed over the past decade, possibly as a result of both improved screening methods as well as the evolution of the natural disease course. Today’s celiac patient is often identified through screening due to a genetic risk for CD, who otherwise would not have sought medical attention for relatively minor symptoms if present at all.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lagerqvist C, Dahlbom I, Hansson T, et al. Antigliadin immunoglobulin A best in finding celiac disease in children younger than 18 months of age. J Pediatr Gastroenterol Nutr 2008;47(4):428–435.
Catassi C, Fabiani E, Iacono G, et al. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr 2007;85(1):160–166.
Simell S, Hoppu S, Hekkala A, et al. Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study. Am J Gastroenterol 2007;102(9):2026–2035.
Norris JM, Barriga K, Hoffenberg EJ, et al. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 2005;293(19):2343–2351.
Stene LC, Honeyman MC, Hoffenberg EJ, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 2006;101(10):2333–2340.
Hansen D, Brock-Jacobsen B, Lund E, et al. Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years’ follow-up. Diab care 2006;29(11):2452–2456.
Simmons JH, Klingensmith GJ, McFann K, et al. Impact of celiac autoimmunity on children with type 1 diabetes. J Pediatr 2007;150(5):461–466.
Amin R, Murphy N, Edge J, Ahmed ML, Acerini CL, Dunger DB. A longitudinal study of the effects of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and celiac disease. Diabetes Care 2002;25(7):1117–1122.
AGA Institute. AGA Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease. Gastroenterology 2006;131(6):1977–1980.
Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005;40(1):1–19.
Silverstein J, Klingensmith G, Copeland K, et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005;28(1):186–212.
Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 1999;117(2):297–303.
Cronin CC, Feighery A, Ferriss JB, Liddy C, Shanahan F, Feighery C. High prevalence of celiac disease among patients with insulin-dependent (type I) diabetes mellitus. Am J Gastroenterol 1997;92(12):2210–2212.
Not T, Tommasini A, Tonini G, et al. Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus. Diabetologia 2001;44(2):151–155.
Ventura A, Neri E, Ughi C, Leopaldi A, Citta A, Not T. Gluten-dependent diabetes-related and thyroid-related autoantibodies in patients with celiac disease. J Pediatr 2000;137(2):263–265.
Neuhausen SL, Steele L, Ryan S, et al. Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. J Autoimmun 2008;31(2):160–165.
Cosnes J, Cellier C, Viola S, et al. Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol 2008;6(7):753–758.
Toscano V, Conti FG, Anastasi E, et al. Importance of gluten in the induction of endocrine autoantibodies and organ dysfunction in adolescent celiac patients. Am J Gastroenterol 2000;95(7):1742–1748.
Hogberg L, Falth-Magnusson K, Grodzinsky E, Stenhammar L. Familial prevalence of coeliac disease: a twenty-year follow-up study. Scand J Gastroenterol 2003;38(1):61–65.
Greco L, Romino R, Coto I, et al. The first large population based twin study of coeliac disease. Gut 2002;50(5):624–628.
Nistico L, Fagnani C, Coto I, et al. Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut 2006;55(6):803–808.
Bevan S, Popat S, Braegger CP, et al. Contribution of the MHC region to the familial risk of coeliac disease. J Med Genet 1999;36(9):687–690.
Hoffenberg EJ, Mackenzie T, Barriga KJ, et al. A prospective study of the incidence of childhood celiac disease. J Pediatr 2003;143(3):308–314.
Hunt KA, Zhernakova A, Turner G, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 2008;40(4):395–402.
van Heel DA, Franke L, Hunt KA, et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007;39(7):827–829.
Romanos J, Barisani D, Trynka G, Zhernakova A, Bardella MT, Wijmenga C. Six new celiac disease loci replicated in an Italian population confirm association to celiac disease. J Med Genet 2009;46(1):60–63.
Smyth DJ, Plagnol V, Walker NM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008;359(26):2767–2777.
van der Sijp JR, Kamm MA, Nightingale JM, et al. Circulating gastrointestinal hormone abnormalities in patients with severe idiopathic constipation. Am J Gastroenterol 1998;93(8):1351–1356.
Ekwall O, Hedstrand H, Grimelius L, et al. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 1998;352(9124):279–283.
Soderbergh A, Myhre AG, Ekwall O, et al. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 2004;89(2):557–562.
Hogenauer C, Meyer RL, Netto GJ, et al. Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I. N Engl J Med 2001;344(4):270–274.
Zhao RH, Baig KM, Wexner SD, et al. Abnormality of peptide YY and pancreatic polypeptide immunoreactive cells in colonic mucosa of patients with colonic inertia. Dig Dis Sci 2004;49(11–12):1786–1790.
Zhao R, Baig MK, Wexner SD, et al. Enterochromaffin and serotonin cells are abnormal for patients with colonic inertia. Dis Colon Rectum 2000;43(6):858–863.
Baig MK, Zhao RH, Woodhouse SL, et al. Variability in serotonin and enterochromaffin cells in patients with colonic inertia and idiopathic diarrhoea as compared to normal controls. Colorectal Dis 2002;4(5):348–354.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Mereiles, L., Li, M., Loo, D., Liu, E. (2011). Celiac Disease and Intestinal Endocrine Autoimmunity. In: Eisenbarth, G. (eds) Immunoendocrinology: Scientific and Clinical Aspects. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-478-4_32
Download citation
DOI: https://doi.org/10.1007/978-1-60327-478-4_32
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60327-477-7
Online ISBN: 978-1-60327-478-4
eBook Packages: MedicineMedicine (R0)